Loading…
Krishna Institute of Medical Sciences (KIMS)₹721.65−1.78%Hospital
At the end of the Jun 2026 quarter, Krishna Institute of Medical Sciences' shareholders were: promoters 32.47%, FIIs 14.70%, DIIs 34.39%, public 18.44%. Promoter holding is down 1.62 percentage points from 34.09% a quarter earlier. FII holding is down 0.79 percentage points from 15.49% a year earlier. 10.29% of promoter shares were pledged. It had 94,743 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 38.83% | 38.80% | 38.80% | 38.80% | 38.80% | 38.80% | 38.80% | 34.09% | 34.09% | 34.09% | 34.09% | 32.47% |
| FIIs | 14.19% | 15.22% | 16.68% | 17.79% | 15.80% | 15.63% | 15.39% | 15.49% | 14.98% | 14.28% | 14.52% | 14.70% |
| DIIs | 34.77% | 34.21% | 33.10% | 32.09% | 32.26% | 32.02% | 31.92% | 31.62% | 32.09% | 32.69% | 32.47% | 34.39% |
| Public | 12.21% | 11.77% | 11.42% | 11.32% | 13.14% | 13.55% | 13.89% | 18.80% | 18.84% | 18.94% | 18.92% | 18.44% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 10.29% |
| Number of shareholders | 66,966 | 71,024 | 69,101 | 69,072 | 77,628 | 95,481 | 1,01,909 | 1,08,970 | 1,04,886 | 1,01,613 | 93,346 | 94,743 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Bhaskara Rao Bollineni | Promoter | 25.07% | −1.25 |
| Bluebridge Capital Private Limited | Promoter | 5.77% | −0.30 |
| Sbi Small Cap Fund | DII | 5.15% | −0.71 |
| Axis Mutual Fund Trustee Limited A/C Axis Mutual Fund A/C Axis Small Cap Fund | DII | 4.48% | +0.17 |
| Hdfc Small Cap Fund | DII | 3.95% | −0.37 |
| Bollineni Seenaiah Naidu | Public | 3.92% | −0.19 |
| Kotak Small Cap Fund | DII | 3.64% | +0.59 |
| Invesco India Flexi Cap Fun | DII | 3.57% | −0.01 |
| Amansa Holdings Private Limited | FII | 2.22% | −0.10 |
| Nippon Life India Trustee Ltd-A/C Nippon India Small Cap Fund | DII | 1.94% | +0.37 |
| Lilac Investments Limited | Public | 1.85% | −0.09 |
| Sbi Life Insurance Co. Ltd | DII | 1.70% | −0.21 |
| Rajyasri Bollinen | Promoter | 1.65% | −0.09 |
| Tata Aia Life Insurance Co Ltd-Whole Life Mid Cap Equity Fund-Ulif 009 04/01/07 Wle 110 | DII | 1.58% | +0.13 |
| Nomura India Investment Fund Mother Fund | FII | 1.49% | −0.09 |
| Hdfc Life Insurance Company Limited | DII | 1.30% | +0.28 |
| Venkata Krishna Kumar Kodali | Public | 1.21% | −0.06 |
| Mirae Asset Small Cap Fund | DII | 1.03% | New |
| Abhinay Bollineni | Promoter | 0.06% | 0.00 |
| Adwik Bollineni | Promoter | 0.01% | 0.00 |
| Sweata Raavi | Promoter | 0.01% | 0.00 |
Promoters held 32.47% of Krishna Institute of Medical Sciences at the end of the Jun 2026 quarter, down 1.62 percentage points from 34.09% a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held 14.70% (up 0.18 percentage points from 14.52% a quarter earlier) and domestic institutions (DIIs) held 34.39% (up 1.92 percentage points from 32.47% a quarter earlier).
Yes. 10.29% of promoter shares were pledged at the end of the Jun 2026 quarter.
Krishna Institute of Medical Sciences had 94,743 shareholders at the end of the Jun 2026 quarter, against 1,08,970 a year earlier.
Sbi Small Cap Fund (DII) held 5.15% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.